A new COVID-19 variant, NB.1.8.1 – nicknamed “Nimbus” – is rapidly emerging as one of the most common strains in the U.S.
According to the CDC, as of late June, NB.1.8.1 made up 43% of COVID-19 cases nationwide.
What is NB.1.8.1?
NB.1.8.1 is a recent offshoot of the LP.8.1 variant, which has been dominant in recent months. It was first detected in China in January and has now spread to at least 22 countries, according to USA TODAY. Virologists describe Nimbus as a “slightly upgraded” version of its predecessor. While there is no evidence it causes more severe disease, it appears to be highly transmissible.
Has NB.1.8.1 been detected in Illinois?
Yes. According to the World Health Network and Global Initiative on Sharing All Influenza Data, NB.1.8.1 has been detected in Illinois, along with at least 17 other U.S. states including California, New Jersey, and New York.
What are the symptoms?
Reported symptoms of NB.1.8.1 are similar to other COVID-19 strains, but one distinctive complaint is a severe sore throat, sometimes described as “razor-blade throat fatigue.” Other symptoms may include:
Are vaccines still effective?
Health experts say that updated COVID-19 vaccines remain the best protection against severe illness. Vaccination rates vary widely by state, and health officials continue to urge eligible individuals to stay current with their shots.
Where to get a COVID-19 vaccine in Illinois?
Vaccines are available at:
To find a vaccination site near you, visit: vaccines.gov.
Check with your local health department or healthcare provider for testing locations near you.
Contributing: USA Today Network
Contributing: Linda Roy, digital producer
This article originally appeared on Rochester Democrat and Chronicle: New COVID variant, ‘Nimbus,’ making up 43% of new US cases, and it’s in Illinois
Reporting by New York Connect Team / Rochester Democrat and Chronicle
USA TODAY Network via Reuters Connect
